{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:39:00Z","timestamp":1790483940908,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.jcp.0000248603.76231.b7","type":"journal-article","created":{"date-parts":[[2006,11,18]],"date-time":"2006-11-18T03:52:02Z","timestamp":1163821922000},"page":"600-609","source":"Crossref","is-referenced-by-count":434,"title":["Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression"],"prefix":"10.1097","volume":"26","author":[{"given":"Michael E.","family":"Thase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Macfadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Weisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Paulsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arifulla","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/10673220500326425","article-title":"Bipolar depression: issues in diagnosis and treatment.","volume":"13","author":"Thase","year":"2005","journal-title":"Harv Rev Psychiatry"},{"key":"R2-9-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder.","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"R3-9-20210128","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4088\/JCP.v64n0209","article-title":"Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder.","volume":"64","author":"Hirschfeld","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R4-9-20210128","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1001\/archpsyc.62.12.1322","article-title":"Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.","volume":"62","author":"Judd","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"R5-9-20210128","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","article-title":"Suicidal behaviour in bipolar disorder: risk and prevention.","volume":"17","author":"Tondo","year":"2003","journal-title":"CNS Drugs"},{"key":"R6-9-20210128","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder. revision.","volume":"159","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R8-9-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/15622970209150612","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.","volume":"3","author":"Grunze","year":"2002","journal-title":"World J Biol Psychiatry"},{"issue":"suppl 15","key":"R9-9-20210128","first-page":"25","article-title":"Defining and improving response to treatment in patients with bipolar disorder.","volume":"65","author":"Keck","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R10-9-20210128","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder.","volume":"66","author":"Suppes","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"suppl 3","key":"R11-9-20210128","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5618.2005.00219.x","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.","volume":"7","author":"Yatham","year":"2005","journal-title":"Bipolar Disord"},{"key":"R12-9-20210128","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0006-3223(00)00980-X","article-title":"Bipolar depression: pharmacotherapy and related therapeutic strategies.","volume":"48","author":"Thase","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R13-9-20210128","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","article-title":"Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression.","volume":"158","author":"Nemeroff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R14-9-20210128","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1520-6394(1997)5:2<73::AID-DA3>3.0.CO;2-6","article-title":"Bipolar depression: an underestimated treatment challenge.","volume":"5","author":"Hlastala","year":"1997","journal-title":"Depress Anxiety"},{"key":"R15-9-20210128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","article-title":"Divalproex in the treatment of bipolar depression: a placebo-controlled study.","volume":"85","author":"Davis","year":"2005","journal-title":"J Affect Disord"},{"key":"R16-9-20210128","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.","volume":"60","author":"Bowden","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R17-9-20210128","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder.","volume":"64","author":"Calabrese","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"R18-9-20210128","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.","volume":"60","author":"Calabrese","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"R21-9-20210128","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/appi.ajp.161.9.1537","article-title":"Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.","volume":"161","author":"Gijsman","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R22-9-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1176\/appi.ajp.163.2.313","article-title":"Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants.","volume":"163","author":"Altshuler","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R23-9-20210128","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1399-5618.2003.00065.x","article-title":"A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.","volume":"5","author":"Post","year":"2003","journal-title":"Bipolar Disord"},{"key":"R20-9-20210128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R24-9-20210128","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R25-9-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R26-9-20210128","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"key":"R27-9-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"R29-9-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating.","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"R31-9-20210128","first-page":"321","article-title":"Quality of life enjoyment and satisfaction questionnaire: a new measure.","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol Bull"},{"key":"R32-9-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects.","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"R33-9-20210128","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia.","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"R34-9-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0165-0327(02)00120-9","article-title":"Differentiating moderate and severe depression using the Montgomery-Asberg Depression Rating Scale (MADRS).","volume":"77","author":"Muller","year":"2003","journal-title":"J Affect Disord"},{"key":"R35-9-20210128","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","article-title":"Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.","volume":"163","author":"Leverich","year":"2006","journal-title":"Am J Psychiatry"},{"key":"R36-9-20210128","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1185\/030079905X46340","article-title":"Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.","volume":"21","author":"Vieta","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R37-9-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/(SICI)1520-6394(1997)6:1<26::AID-DA4>3.0.CO;2-3","article-title":"Effect size of efficacy measures comparing divalproex, lithium and placebo in acute mania.","volume":"6","author":"Bowden","year":"1997","journal-title":"Depress Anxiety"},{"issue":"suppl 5","key":"R38-9-20210128","first-page":"26","article-title":"Clinical highlights in bipolar depression: focus on atypical antipsychotics.","volume":"66","author":"Calabrese","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R39-9-20210128","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/sim.1526","article-title":"Gatekeeping strategies for clinical trials that do not require all primary effects to be significant.","volume":"22","author":"Dmitrienko","year":"2003","journal-title":"Stat Med"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-200612000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T04:48:41Z","timestamp":1618030121000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-200612000-00009"}},"subtitle":["A Double-blind, Placebo-controlled Study (The BOLDER II Study)"],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jcp.0000248603.76231.b7","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}